SnoreLab Competitors

Headspace exists to provide every person access to lifelong mental health support. We combine evidence-based content, clinical care, and innovative technology to help millions of members around the world get support that’s effective, personalized, and truly accessible whenever and wherever they need it. To learn more, please visit headspace.com. At Headspace, our values aren’t just what we believe, they’re how we work, grow, and make an impact together. We live them daily: Make the Mission Matter, Iterate to Great, Own the Outcome, and Connect with Courage. These values shape our decisions, guide our collaborations, and define our culture. They’re our shared commitment to building a more connected, human-centered team—one that’s redefining how mental health care supports people today and for generations to come.

Calm is a leading mental health company on a mission to support everyone on every step of their mental health journey. Our flagship consumer app—ranked #1 in its category with over 180 million downloads and available in seven languages across nearly 190 countries—helps people sleep better, stress less, and live more mindfully through content and tools from experts and beloved celebrity voices. Since our launch, we’ve expanded our offerings with Calm Sleep, an app providing deeper, personalized sleep support, and Calm Health, an evidence-based digital solution offered through employers, health plans, and providers to expand access, boost benefits engagement, and drive positive health outcomes. Today, Calm supports more than 3,500 organizations and reaches over 26 million covered lives through Calm Health. Recognized as a TIME100 Most Influential Company and one of Fast Company’s Brands That Matter, Calm was co-founded by Alex Tew (Million Dollar Homepage) and Michael Acton Smith (Mind Candy, Moshi Monsters, Firebox).

Founded in 2004, SomnoMed® is an Australian Stock Exchange listed medical device company operating in 28 countries. With headquarters in Sydney, Australia and offices in Europe and the United States, SomnoMed® focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). More than 625,000 patients around the world with mild and moderate OSA have been successfully treated with our oral appliances. SomnoMed® leads the world in the development of OSA devices with each appliance custom made using state-of-the-art technology delivering precision, comfort, and first-time fit solutions. SomnoMed®’s continuous improvement has ensured oral sleep medicine devices have greater efficacy and are more comfortable than ever. Our devices are 510(k) cleared by the FDA (Food and Drug Administration), TGA (Therapeutic Goods Administration) listed and manufactured in accordance with ISO 13485 quality standards. At SomnoMed®, we are committed to providing comfortable and effective OSA treatment that is effective and clinically proven to treat Obstructive Sleep Apnea (OSA). Our passion is to help patients regain their lives again by having a comfortable night sleep.